BluePath Capital Management’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
19,827
-103
-0.5% -$6.22K 0.67% 53
2026
Q1
$1.17M Buy
19,930
+755
+4% +$44.7K 0.8% 40
2025
Q4
$1.09M Buy
19,175
+2,588
+16% +$141K 0.73% 53
2025
Q3
$880K Buy
16,587
+3,368
+25% +$183K 0.64% 60
2025
Q2
$626K Sell
13,219
-597
-4% -$26.4K 0.55% 65
2025
Q1
$572K Sell
13,816
-8,591
-38% -$338K 0.59% 54
2024
Q4
$792K Buy
22,407
+4,075
+22% +$147K 0.43% 67
2024
Q3
$671K Sell
18,332
-4,144
-18% -$148K 0.41% 67
2024
Q2
$695K Buy
22,476
+3,085
+16% +$93.7K 0.49% 59
2024
Q1
$591K Buy
19,391
+1,578
+9% +$47.5K 0.45% 49
2023
Q4
$535K Buy
17,813
+3,277
+23% +$99.7K 0.46% 51
2023
Q3
$457K Buy
+14,536
New +$479K 0.42% 46

Other funds holding BTI

BluePath Capital Management's BTI Position: Q2 2026 in Review

BluePath Capital Management reduced its British American Tobacco (BTI) stake by 0.52% in Q2 2026, selling an estimated $6.22K and leaving 19,827 shares worth $1.22M. The position accounts for 0.67% of the portfolio, ranked #53.

BluePath Capital Management first reported a position in BTI in Q3 2023 and has held it in 12 quarters since. 907 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • BluePath Capital Management held 19,827 shares of British American Tobacco worth $1.22M as of Q2 2026.
  • BluePath Capital Management sold 103 British American Tobacco shares in Q2 2026, an estimated $6.22K.
  • British American Tobacco made up 0.67% of BluePath Capital Management's portfolio in Q2 2026, its #53 holding.
  • BluePath Capital Management first reported a position in British American Tobacco in Q3 2023 and has held it in 12 quarters since.
  • 907 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.